Vaccines in 2017: Closing in on a Zika virus vaccine

Nat Rev Immunol. 2018 Feb;18(2):89-90. doi: 10.1038/nri.2017.132. Epub 2017 Dec 4.

Authors

Michael S Diamond¹, Carolyn B Coyne²

Affiliations

¹ Departments of Medicine, Pathology and Immunology, and Molecular Microbiology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, Missouri 63110, USA.
² Department of Pediatrics, and The Center for Microbial Pathogenesis, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15224, USA.

PMID: 29199280
DOI: 10.1038/nri.2017.132

No abstract available

Publication types

Review

MeSH terms

Adult
Animals
CD8-Positive T-Lymphocytes / immunology
Drug Discovery
Female
Humans
Immunologic Techniques
Infant, Newborn
Pregnancy
Vaccines, Attenuated / genetics
Vaccines, Attenuated / immunology
Vaccines, Subunit / genetics
Vaccines, Subunit / immunology
Viral Vaccines / genetics
Viral Vaccines / immunology*
Viral Vaccines / therapeutic use
Zika Virus / genetics
Zika Virus / immunology*
Zika Virus / pathogenicity
Zika Virus Infection / congenital
Zika Virus Infection / immunology*
Zika Virus Infection / prevention & control*

Substances

Vaccines, Attenuated
Vaccines, Subunit
Viral Vaccines